Hyperfine (HYPR) Q3 2026 Earnings Call Transcript
Hyperfine, Inc. Q3 2026 Earnings Call Summary
Hyperfine Inc (HYPR) Q3 2026 Earnings Call Highlights: Record Revenue, 73% Growth, and First ...
Hyperfine, Inc. (HYPR) Q3 2026 Earnings Call Transcript
What Hyperfine (HYPR) Said on Its Q3 Earnings Call
Hyperfine, Inc. Reports Third Quarter 2026 Financial Results
Hyperfine Q3 2026 Earnings Call Transcript
Hyperfine Files Prospectus Offering $150M Mixed Shelf
Hyperfine Affirms FY2026 Sales Guidance of $20.000M-$22.000M vs $20.425M Est
Hyperfine Q3 EPS $(0.06) Beats $(0.08) Estimate, Sales $5.960M Beat $5.840M Estimate
Lucid Capital Markets Initiates Coverage On Hyperfine with Buy Rating, Announces Price Target of $2
Hyperfine Advances International Swoop System Model 2 Rollout and Highlights the Role of Portable MRI in Brain Health Awareness
Full Transcript: Hyperfine Q2 2026 Earnings Call
Hyperfine Reports Record Preliminary Q3 Revenue of $6 Million, Up 53% Sequentially
Hyperfine, Inc. to Announce Third Quarter 2026 Financial Results on November 9, 2026
Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million
Hyperfine Affirms FY2026 Sales Guidance of $20.000M-$22.000M vs $20.163M Est
Hyperfine Expands Global Access to Portable Brain MRI Technology Across Key Gulf Cooperation Council Healthcare Markets
BTIG Reiterates Buy on Hyperfine, Maintains $2 Price Target
MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.